Precancerous lesions in the stomach: From biology to clinical patient management

Best Practice and Research: Clinical Gastroenterology

Volumn 27, Issue 2, 2013, Pages 205-223

  Rugge, Massimo ^a   Capelle, Lisette G ^b   Cappellesso, Rocco ^a   Nitti, Donato ^a   Kuipers, Ernst J ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Gastric cancer; Gastritis; Gastritis staging; Precancerous gastric lesions

Indexed keywords

ANTIOXIDANT; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2 INHIBITOR; VITAMIN;

ARTICLE; ATROPHIC GASTRITIS; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER GROWTH; CANCER SCREENING; CLINICAL PRACTICE; DISEASE CLASSIFICATION; FOLLOW UP; GASTRIC INTRAEPITHELIAL NEOPLASIA; GASTRITIS; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL EPITHELIAL NEOPLASIA; GENOMIC INSTABILITY; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; MEDICAL TERMINOLOGY; ONCOGENE; PATIENT CARE; PRECANCER; STOMACH; STOMACH ATROPHY; STOMACH CANCER; STOMACH MUCOSA LESION; TUMOR SUPPRESSOR GENE; WORLD HEALTH ORGANIZATION;

EID: 84879788200     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2012.12.007     Document Type: Review

References (115)

1. P. Correa A human model of gastric carcinogenesis Cancer Res 48 1988 3554 3560
2. P. Correa The biological model of gastric carcinogenesis IARC Sci Publ 157 2004 301 310
3. P. Correa Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res 52 1992 6735 6740
4. B.C. Morson, L.H. Sobin, E. Grundmann, A. Johansen, T. Nagayo, and A. Serck-Hanssen Precancerous conditions and epithelial dysplasia in the stomach J Clin Pathol 33 1980 711 721
5. L.G. Capelle, N.C. Van Grieken, H.F. Lingsma, E.W. Steyerberg, W.J. Klokman, and M.J. Bruno Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands Gastroenterology 138 2010 487 492
6. B. Humar, V. Blair, A. Charlton, H. More, I. Martin, and P. Guilford E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man Cancer Res 69 2009 2050 2056
7. M. Barber, A. Murrell, Y. Ito, A.T. Maia, S. Hyland, and C. Oliveira Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer J Pathol 216 2008 295 306
8. D.G. Huntsman, F. Carneiro, F.R. Lewis, P.M. MacLeod, A. Hayashi, and K.G. Monaghan Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations N Engl J Med 344 2001 1904 1909
9. G. Oberhuber, and M. Stolte Gastric polyps: an update of their pathology and biological significance Virchows Arch 437 2000 581 590
10. K. Dirschmid, C. Platz-Baudin, and M. Stolte Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch 448 2006 80 84
11. D.Y. Graham, and R.M. Genta Long-term proton pump inhibitor use and gastrointestinal cancer Curr Gastroenterol Rep 10 2008 543 547
12. K. Borch, J. Skarsgard, L. Franzen, S. Mardh, and J.F. Rehfeld Benign gastric polyps: morphological and functional origin Dig Dis Sci 48 2003 1292 1297
13. M.F. Dixon, R.M. Genta, J.H. Yardley, and P. Correa Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 Am J Surg Pathol 20 1996 1161 1181
14. B. Ruiz, J. Garay, W. Johnson, D. Li, M. Rugge, and M.F. Dixon Morphometric assessment of gastric antral atrophy: comparison with visual evaluation Histopathology 39 2001 235 242
15. M. Rugge, P. Correa, M.F. Dixon, R. Fiocca, T. Hattori, and J. Lechago Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading Aliment Pharmacol Ther 16 2002 1249 1259
16. A.B. Price The Sydney System: histological division J Gastroenterol Hepatol 6 1991 209 222
17. H.M. El-Zimaity, J. Ramchatesingh, M.A. Saeed, and D.Y. Graham Gastric intestinal metaplasia: subtypes and natural history J Clin Pathol 54 2001 679 683
18. G.J. Offerhaus, A.B. Price, J. Haot, F.J. ten Kate, P. Sipponen, and R. Fiocca Observer agreement on the grading of gastric atrophy Histopathology 34 1999 320 325
19. J.R. Jass, and M.I. Filipe The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma Histochem J 13 1981 931 939
20. M. Cassaro, M. Rugge, O. Gutierrez, G. Leandro, D.Y. Graham, and R.M. Genta Topographic patterns of intestinal metaplasia and gastric cancer Am J Gastroenterol 95 2000 1431 1438
21. W.K. Leung, S.R. Lin, J.Y. Ching, K.F. To, E.K. Ng, and F.K. Chan Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication Gut 53 2004 1244 1249
22. M. Rugge, M. Fassan, M. Pizzi, V. Zorzetto, G. Maddalo, and S. Realdon Autoimmune gastritis: histology phenotype and OLGA staging Aliment Pharmacol Ther 35 2012 1460 1466
23. E. Grundmann Histologic types and possible initial stages in early gastric carcinoma Beitr Pathol 154 3 1975 256 280
24. W. Oehlert, P. Keller, M. Henke, and M. Strauch Gastric mucosal dysplasias: what is their clinical significance? (author's transl) Dtsch Med Wochenschr 100 1975 1950 1956
25. J.R. Jass A classification of gastric dysplasia Histopathology 7 1983 181 193
26. S.C. Ming, A. Bajtai, P. Correa, K. Elster, O.H. Jarvi, and N. Munoz Gastric dysplasia. Significance and pathologic criteria Cancer 54 1984 1794 1801
27. R.H. Riddell Premalignant and early malignant lesions in the gastrointestinal tract: definitions, terminology, and problems Am J Gastroenterol 91 1996 864 872
28. N.S. Goldstein, and K.J. Lewin Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading Hum Pathol 28 1997 127 133
29. K.J. Lewin Nomenclature problems of gastrointestinal epithelial neoplasia Am J Surg Pathol 22 1998 1043 1047
30. R.H. Riddell, and M. Iwafuchi Problems arising from Eastern and Western classification systems for gastrointestinal dysplasia and carcinoma: are they resolvable? Histopathology 33 1998 197 202
31. G.Y. Lauwers, and R.H. Riddell Gastric epithelial dysplasia Gut 45 1999 784 790
32. K. Takagi, K. Kumakura, H. Sugano, and K. Nakamura Polypoid lesions of the stomach - with special reference to atypical epithelial lesions Gan No Rinsho 13 1967 809 817
33. T. Nagayo Histological diagnosis of biopsied gastric mucosae with special reference to that of borderline lesions Gann Monogr 11 1971 245 256
34. Japanese classification of gastric carcinoma 1995 Kanehara & Company, Ltd Tokyo
35. C.M. Fenoglio-Preiser, F. Carneiro, P. Correa, P. Guildford, R. Lambert, and F. Megraud Gastric carcinoma S.R. Hamilton, L.A. Aaltonen, Pathology and genetics, tumors of the digestive system 3rd ed. 2000 IARC Press Lyon 39 52
36. M. Rugge, P. Correa, M.F. Dixon, T. Hattori, G. Leandro, and K. Lewin Gastric dysplasia: the Padova international classification Am J Surg Pathol 24 2000 167 176
37. M. Fassan, M. Pizzi, F. Farinati, D. Nitti, V. Zagonel, and R.M. Genta Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy Am J Clin Pathol 137 2012 727 732
38. R.J. Schlemper, R.H. Riddell, Y. Kato, F. Borchard, H.S. Cooper, and S.M. Dawsey The Vienna classification of gastrointestinal epithelial neoplasia Gut 47 2000 251 255
39. F.T. Bosman, F. Carneiro, R.H. Hruban, and N.D. Theise World Health Organization classification of tumours of the digestive system 4th ed. 2010 IARC Press Lyon
40. J. Houghton, C. Stoicov, S. Nomura, A.B. Rogers, J. Carlson, and H. Li Gastric cancer originating from bone marrow-derived cells Science 306 2004 1568 1571
41. S.M. Karam Cellular origin of gastric cancer Ann N Y Acad Sci 1138 2008 162 168
42. W. El-Rifai, and S.M. Powell Molecular biology of gastric cancer Semin Radiat Oncol 12 2002 128 140
43. M. Rugge, G. Bersani, R. Bertorelle, G. Pennelli, V.M. Russo, and F. Farinati Microsatellite instability and gastric non-invasive neoplasia in a high-risk population in Cesena, Italy J Clin Pathol 58 2005 805 810
44. Z. Jin, G. Tamura, T. Honda, and T. Motoyama Molecular and cellular phenotypic profiles of gastric noninvasive neoplasia Lab Invest 82 2002 1637 1645
45. N. Homma, G. Tamura, T. Honda, Z. Jin, K. Ohmura, and S. Kawata Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias Virchows Arch 446 2005 120 126
46. J.M. Chong, M. Fukayama, Y. Hayashi, T. Takizawa, M. Koike, and M. Konishi Microsatellite instability in the progression of gastric carcinoma Cancer Res 54 1994 4595 4597
47. R. Seruca, N.R. Santos, L. David, M. Constancia, H. Barroca, and F. Carneiro Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile Int J Cancer 64 1995 32 36
48. J. Isogaki, K. Shinmura, W. Yin, T. Arai, K. Koda, and T. Kimura Microsatellite instability and K-ras mutations in gastric adenomas, with reference to associated gastric cancers Cancer Detect Prev 23 1999 204 214
49. J.H. Lee, S.C. Abraham, H.S. Kim, J.H. Nam, C. Choi, and M.C. Lee Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma Am J Pathol 161 2002 611 618
50. S. Semba, H. Yokozaki, S. Yamamoto, W. Yasui, and E. Tahara Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach Cancer 77 Suppl. 8 1996 1620 1627
51. S. Sakurai, T. Sano, and T. Nakajima Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality Pathol Int 45 1995 51 57
52. G. Tamura, C. Maesawa, Y. Suzuki, H. Tamada, M. Satoh, and S. Ogasawara Mutations of the APC gene occur during early stages of gastric adenoma development Cancer Res 54 1994 1149 1151
53. H. Tohdo, H. Yokozaki, K. Haruma, G. Kajiyama, and E. Tahara P53 gene mutations in gastric adenomas Virchows Arch B Cell Pathol Incl Mol Pathol 63 1993 191 195
54. O. Lefebvre, M.P. Chenard, R. Masson, J. Linares, A. Dierich, and M. LeMeur Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein Science 274 1996 259 262
55. E. Tahara, H. Yokozaki, and W. Yasui Stomach-genetic and epigenetic alterations of preneoplastic and neoplastic lesions S. Srivastava, D.E. Henson, A. Gazdar, Molecular pathology of early cancer 1999 AIOS-Press Ohmsha, Amsterdam, Berlin, Oxford, Tokyo, Washington DC 341 364
56. K.F. Becker, M.J. Atkinson, U. Reich, I. Becker, H. Nekarda, and J.R. Siewert E-cadherin gene mutations provide clues to diffuse type gastric carcinomas Cancer Res 54 1994 3845 3852
57. K. Higashikawa, H. Yokozaki, T. Ue, K. Taniyama, T. Ishikawa, and D. Tarin Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues Int J Cancer 66 1996 11 17
58. A.C. de Vries, N.C. van Grieken, C.W. Looman, M.K. Casparie, E. de Vries, and G.A. Meijer Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands Gastroenterology 134 2008 945 952
59. S.D. Saini, G. Eisen, N. Mattek, and P. Schoenfeld Utilization of upper endoscopy for surveillance of gastric ulcers in the United States Am J Gastroenterol 103 2008 1920 1925
60. M. Dinis-Ribeiro, M. Areia, A.C. de Vries, R. Marcos-Pinto, M. Monteiro-Soares, and A. O'Connor Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) Endoscopy 44 2012 74 94
61. T. Rokkas, D. Pistiolas, P. Sechopoulos, I. Robotis, and G. Margantinis The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis Helicobacter 12 Suppl. 2 2007 32 38
62. J. Wang, L. Xu, R. Shi, X. Huang, S.W. Li, and Z. Huang Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis Digestion 83 2011 253 260
63. A.C. De Vries, and E.J. Kuipers Review article: Helicobacter pylori eradication for the prevention of gastric cancer Aliment Pharmacol Ther 26 Suppl. 2 2007 25 35
64. P. Correa, E.T. Fontham, J.C. Bravo, L.E. Bravo, B. Ruiz, and G. Zarama Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy J Natl Cancer Inst 92 2000 1881 1888
65. K. Satoh, K. Kimura, T. Takimoto, and K. Kihira A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori Helicobacter 3 1998 236 240
66. W.H. Wang, J.Q. Huang, G.F. Zheng, S.K. Lam, J. Karlberg, and B.C. Wong Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis J Natl Cancer Inst 95 2003 1784 1791
67. W. Tian, Y. Zhao, S. Liu, and X. Li Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer Eur J Cancer Prev 19 2010 288 298
68. L.J. Zhang, S.Y. Wang, X.H. Huo, Z.L. Zhu, J.K. Chu, and J.C. Ma Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions World J Gastroenterol 15 2009 2731 2738
69. K.H. Hung, H.B. Yang, H.C. Cheng, J.J. Wu, and B.S. Sheu Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication J Gastroenterol Hepatol 25 2010 48 53
70. H.B. Yang, H.C. Cheng, B.S. Sheu, K.H. Hung, M.F. Liou, and J.J. Wu Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication Aliment Pharmacol Ther 25 2007 455 461
71. W.K. Leung, E.K. Ng, F.K. Chan, W.Y. Chan, K.F. Chan, and A.C. Auyeung Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial Clin Cancer Res 12 2006 4766 4772
72. K. Yanaoka, M. Oka, N. Yoshimura, H. Deguchi, C. Mukoubayashi, and S. Enomoto Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion Int J Cancer 126 2010 1467 1473
73. M. Plummer, J. Vivas, G. Lopez, J.C. Bravo, S. Peraza, and E. Carillo Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population J Natl Cancer Inst 99 2007 137 146
74. W.C. You, L.M. Brown, L. Zhang, J.Y. Li, M.L. Jin, and Y.S. Chang Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions J Natl Cancer Inst 98 2006 974 983
75. T. Kirchner, S. Muller, T. Hattori, K. Mukaisyo, T. Papadopoulos, and T. Brabletz Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis Virchows Arch 439 2001 512 522
76. T. Hattori Development of adenocarcinomas in the stomach Cancer 57 1986 1528 1534
77. A. Srivastava, and G.Y. Lauwers Gastric epithelial dysplasia: the Western perspective Dig Liver Dis 40 2008 641 649
78. A.C. de Vries, G.A. Meijer, C.W. Looman, M.K. Casparie, B.E. Hansen, and N.C. van Grieken Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands Gut 56 2007 1665 1670
79. M. Rugge Secondary prevention of gastric cancer Gut 56 2007 1646 1647
80. M. Rugge, A. Meggio, G. Pennelli, F. Piscioli, L. Giacomelli, and G. De Pretis Gastritis staging in clinical practice: the OLGA staging system Gut 56 2007 631 636
81. M. Rugge, F. Farinati, R. Baffa, F. Sonego, F. Di Mario, and G. Leandro Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia Gastroenterology 107 1994 1288 1296
82. M. Rugge, M. Cassaro, F. Di Mario, G. Leo, G. Leandro, and V.M. Russo The long-term outcome of gastric non-invasive neoplasia Gut 52 2003 1111 1116
83. M. Rugge, M. Cassaro, G. Pennelli, V.M. Russo, F. Di Mario, and F. Farinati Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions Gut 52 2003 453 454
84. S.B. Garcia, H.S. Park, M. Novelli, and N.A. Wright Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets J Pathol 187 1999 61 81
85. S.A. McDonald, L.C. Greaves, L. Gutierrez-Gonzalez, M. Rodriguez-Justo, M. Deheragoda, and S.J. Leedham Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells Gastroenterology 134 2008 500 510
86. Y.Q. Bai, H. Yamamoto, Y. Akiyama, H. Tanaka, T. Takizawa, and M. Koike Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach Cancer Lett 176 2002 47 55
87. M. Rugge, G. Ingravallo, F. Farinati, V.M. Russo, G. Zaninotto, and V. Alvisi Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia Am J Surg Pathol 28 2004 834 835 [author's reply 835]
88. M. Fassan, C.M. Croce, and M. Rugge miRNAs in precancerous lesions of the gastrointestinal tract World J Gastroenterol 17 2011 5231 5239
89. F. Tava, O. Luinetti, M.R. Ghigna, C. Alvisi, M. Perego, and E. Trespi Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia Hum Pathol 37 2006 1489 1497
90. S.C. Raftopoulos, P. Kumarasinghe, B. de Boer, J. Iacobelli, N. Kontorinis, and S. Fermoyle Gastric intraepithelial neoplasia in a Western population Eur J Gastroenterol Hepatol 24 2012 48 54
91. R. Mera, E.T. Fontham, L.E. Bravo, J.C. Bravo, M.B. Piazuelo, and M.C. Camargo Long-term follow-up of patients treated for Helicobacter pylori infection Gut 54 2005 1536 1540
92. M. Rugge, V.M. Russo, and M. Guido Review article: what have we learnt from gastric biopsy? Aliment Pharmacol Ther 17 Suppl. 2 2003 68 74
93. S.J. Cho, I.J. Choi, C.G. Kim, J.Y. Lee, M.C. Kook, and S. Park Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification Endoscopy 43 2011 465 471
94. A. Oshima, N. Hirata, T. Ubukata, K. Umeda, and I. Fujimoto Evaluation of a mass screening program for stomach cancer with a case-control study design Int J Cancer 38 1986 829 833
95. K.J. Lee, M. Inoue, T. Otani, M. Iwasaki, S. Sasazuki, and S. Tsugane Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan Int J Cancer 118 2006 2315 2321
96. H. Vaananen, M. Vauhkonen, T. Helske, I. Kaariainen, M. Rasmussen, and H. Tunturi-Hihnala Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study Eur J Gastroenterol Hepatol 15 2003 885 891
97. H. Watabe, T. Mitsushima, Y. Yamaji, M. Okamoto, R. Wada, and T. Kokubo Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study Gut 54 2005 764 768
98. A.C. de Vries, J. Haringsma, and E.J. Kuipers The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection Helicobacter 12 2007 1 15
99. A.C. de Vries, J. Haringsma, R.A. de Vries, F. ter Borg, N.M. Nagtzaam, and E.W. Steyerberg The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice Gastrointest Endosc 70 2009 18 25
100. M. Rugge, R.M. Genta OLGA Group Staging gastritis: an international proposal Gastroenterology 129 2005 1807 1808
101. M. Rugge, P. Correa, F. Di Mario, E. El-Omar, R. Fiocca, and K. Geboes OLGA staging for gastritis: a tutorial Dig Liver Dis 40 2008 650 658
102. K. Satoh, H. Osawa, M. Yoshizawa, H. Nakano, T. Hirasawa, and K. Kihira Assessment of atrophic gastritis using the OLGA system Helicobacter 13 2008 225 229
103. L.G. Capelle, A.C. de Vries, J. Haringsma, F. Ter Borg, R.A. de Vries, and M.J. Bruno The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis Gastrointest Endosc 71 2010 1150 1158
104. P. Malfertheiner, F. Megraud, C.A. O'Morain, J. Atherton, A.T. Axon, and F. Bazzoli Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report Gut 61 2012 646 664
105. M. Rugge, M. Fassan, and D.Y. Graham Clinical guidelines: secondary prevention of gastric cancer Nat Rev Gastroenterol Hepatol 9 2012 128 129
106. W.C. You, J.Y. Li, W.J. Blot, Y.S. Chang, M.L. Jin, and M.H. Gail Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer Int J Cancer 83 1999 615 619
107. M. Rugge, G. Leandro, F. Farinati, F. Di Mario, F. Sonego, and M. Cassaro Gastric epithelial dysplasia. How clinicopathologic background relates to management Cancer 76 1995 376 382
108. Y.J. Kim, J.C. Park, J.H. Kim, S.K. Shin, S.K. Lee, and Y.C. Lee Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions Endoscopy 42 2010 620 626
109. R.M. Genta, and M. Rugge Gastric precancerous lesions: heading for an international consensus Gut 45 Suppl. 1 1999 I5 I8
110. R.M. Genta, and M. Rugge Review article: pre-neoplastic states of the gastric mucosa - a practical approach for the perplexed clinician Aliment Pharmacol Ther 15 Suppl. 1 2001 43 50
111. W.M. Weinstein, and N.S. Goldstein Gastric dysplasia and its management Gastroenterology 107 1994 1543 1545
112. I. Bearzi, D. Brancorsini, A. Santinelli, B. Rezai, B. Mannello, and R. Ranaldi Gastric dysplasia: a ten-year follow-up study Pathol Res Pract 190 1994 61 68
113. M. Lansdown, P. Quirke, M.F. Dixon, A.T. Axon, and D. Johnston High-grade dysplasia of the gastric mucosa: a marker for gastric carcinoma Gut 31 1990 977 983
114. S.Y. Park, S.W. Jeon, M.K. Jung, C.M. Cho, W.Y. Tak, and Y.O. Kweon Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma Eur J Gastroenterol Hepatol 20 2008 966 970
115. H. Yamada, M. Ikegami, T. Shimoda, N. Takagi, and M. Maruyama Long-term follow-up study of gastric adenoma/dysplasia Endoscopy 36 2004 390 396